stockrowCognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Revenue
- +16.9%
- EPS
- +79.2%
- Free cash flow
- +67.3%
Quarter to June 2026, against a year earlier
Follow CGNX
Alert me
Cognex Corporation (CGNX) Shares outstanding
Cognex Corporation's shares outstanding at the end of fiscal 2025 was $169.4M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $170.0M. Over the past ten years it has ranged from $169.4M (fiscal 2025) to $179.9M (fiscal 2021) — the current reading is the lowest in ten years. Cognex Corporation ranks 7th of 33 Scientific & Technical Instruments companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $169.4M | (1.88%) |
| FY2024 | $172.6M | (0.45%) |
| FY2023 | $173.4M | (0.84%) |
| FY2022 | $174.9M | (2.81%) |
| FY2021 | $179.9M | 1.88% |
| FY2020 | $176.6M | 0.75% |
| FY2019 | $175.3M | (1.20%) |
| FY2018 | $177.4M | (1.19%) |
| FY2017 | $179.6M | 3.10% |
| FY2016 | $174.1M | (1.04%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $170.0M | 0.95% |
| Mar 2026 | $168.4M | (0.58%) |
| Dec 2025 | $169.4M | 0.03% |
| Sep 2025 | $169.3M | 0.45% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| FTV Fortive Corporation compare | $303.9M |
| TRMB Trimble Inc. compare | $233.0M |
| CGNX Cognex Corporation | $170.0M |
| ST Sensata Technologies Holding N.V. compare | $147.0M |
| VNT Vontier Corporation compare | $139.8M |
| MKSI MKS Inc. compare | $72.7M |
| NOVT Novanta Inc. compare | $41.2M |
| BMI Badger Meter, Inc. compare | $28.9M |
| ESE ESCO Technologies Inc. compare | $26.0M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CGNX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement